Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Helen Branswell joins us to break down what’s known, unknown, and yet to come for the viral outbreak in China. Then, we talk about this week’s World Economic Forum, which has turned out not to be a venue for substantive discussions about drug development. Finally, our colleague Matthew Herper dials in to discuss the latest twist in the Sarepta Therapeutics saga and why it has some people alarmed about the future of the FDA.
For more on what we cover, here’s the latest on the Wuhan virus; here’s Biogen’s Davos panel; and here’s the Sarepta news.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
